Literature DB >> 2465937

Factors influencing the results of vitreous surgery in diabetic retinopathy. I. Iris rubeosis and/or active neovascularization at the fundus.

J Oldendoerp1, M Spitznas.   

Abstract

A consecutive series of 100 vitrectomies for tractional retinal detachment involving the macula in proliferative diabetic retinopathy was analyzed to determine the influence of preoperative iris rubeosis (NVI) and active neovascularization at the fundus (NVF) on surgical results. The minimum follow-up was 12 months. Preoperatively, iris rubeosis was present in 52% and active neovascularization at the fundus in 85%. Surgery was performed under Spitznas wide-angle observation, using a stereoscopic diagonal inverter, either with the panfundoscope or binocular ophthalmoscopy through the operating microscope. Most of the eyes were phakic (94%). No lensectomy was performed. Anatomical success was achieved in 81%, ambulatory vision in 77%. Anatomical success was reduced to 63% in cases with preoperative NVI and to 78% in cases with preoperative NVF. Including 5 cases of re-vitrectomy, silicone oil was used for internal tamponade in 9%, SF 6/air 50:50 in 39% and air in 26%. In 26%, no internal tamponade was applied. Postoperative complications consisted of vitreous hemorrhage (25%), increased rubeosis (22%), neovascular glaucoma (2%), and redetachment (7%). The final causes of failure in 19% of eyes were: neovascular glaucoma (1%), rubeosis/hypotony/cataract (14%), and phthisis bulbi (4%).

Entities:  

Mesh:

Year:  1989        PMID: 2465937     DOI: 10.1007/bf02169815

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  24 in total

1.  Results of vitrectomy for proliferative diabetic retinopathy.

Authors:  J T Thompson; S de Bustros; R G Michels; T A Rice; B M Glaser
Journal:  Ophthalmology       Date:  1986-12       Impact factor: 12.079

2.  [Temporary silicone oil implantation following vitrectomy in proliferative diabetic retinopathy].

Authors:  H Gnad; C Skorpik; P Paroussis; R Menapace; T M Radda; F H Prskavec; M Grasl
Journal:  Klin Monbl Augenheilkd       Date:  1986-11       Impact factor: 0.700

3.  A binocular indirect ophthalmomicroscope (BIOM) for non-contact wide-angle vitreous surgery.

Authors:  M Spitznas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

4.  Vitrectomy for diabetic vitreous hemorrhage.

Authors:  R G Michels; T A Rice; E F Rice
Journal:  Am J Ophthalmol       Date:  1983-01       Impact factor: 5.258

5.  Vitrectomy for diabetic traction retinal detachment involving the macula.

Authors:  T A Rice; R G Michels; E F Rice
Journal:  Am J Ophthalmol       Date:  1983-01       Impact factor: 5.258

6.  Preoperative iris rubeosis and diabetic vitrectomy results.

Authors:  G Blankenship
Journal:  Ophthalmology       Date:  1980-03       Impact factor: 12.079

7.  Long-term diabetic vitrectomy results. Report of 10 year follow-up.

Authors:  G W Blankenship; R Machemer
Journal:  Ophthalmology       Date:  1985-04       Impact factor: 12.079

8.  The lens and pars plana vitrectomy for diabetic retinopathy complications.

Authors:  G Blankenship; R Cortez; R Machemer
Journal:  Arch Ophthalmol       Date:  1979-07

9.  Closed vitrectomy in the management of diabetic traction retinal detachment.

Authors:  F I Tolentino; H M Freeman; F L Tolentino
Journal:  Ophthalmology       Date:  1980-11       Impact factor: 12.079

10.  Vitrectomy for proliferative diabetic retinopathy associated with vitreous hemorrhage.

Authors:  R Machemer; G Blankenship
Journal:  Ophthalmology       Date:  1981-07       Impact factor: 12.079

View more
  6 in total

Review 1.  The pars plana incision: experimental studies, pathologic observations, and clinical experience.

Authors:  A E Krieger
Journal:  Trans Am Ophthalmol Soc       Date:  1991

2.  Ahmed valve implantation for neovascular glaucoma after 23-gauge vitrectomy in eyes with proliferative diabetic retinopathy.

Authors:  Yu Cheng; Xiao-Hong Liu; Xi Shen; Yi-Sheng Zhong
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

Review 3.  [Surgical treatment of diabetic retinopathy and maculopathy].

Authors:  A M Joussen; H Llacer; J Mazciewicz; B Kirchhof
Journal:  Ophthalmologe       Date:  2004-12       Impact factor: 1.059

4.  Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy.

Authors:  Jin-Woo Kwon; Donghyun Jee; Tae Yoon La
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

5.  Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.

Authors:  Masashi Sakamoto; Ryuya Hashimoto; Izumi Yoshida; Makoto Ubuka; Takatoshi Maeno
Journal:  Clin Ophthalmol       Date:  2018-11-14

6.  Frequency and Risk Factors for Neovascular Glaucoma After Vitrectomy in Eyes with Diabetic Retinopathy: An Observational Study.

Authors:  Xu Liang; Yue Zhang; Yu-Peng Li; Wan-Rong Huang; Jia-Xing Wang; Xuan Li
Journal:  Diabetes Ther       Date:  2019-07-18       Impact factor: 2.945

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.